BCL6B and breast cancer: Previous studies suggested that ZBTB16 suppresses breast cancer development and progression by upregulating ZBTB28 and inhibiting ZBTB27.40 However, the specific interactions between ZBTB16 and G6PD, as well as the role of ZBTB16 in G6PD ubiquitination remain unclear.